CRIP2 and malignant colon neoplasm: Similarly, CRIP2 has shown great potential in the diagnosis and prediction of diseases such as esophageal cancer [69], non-small cell lung cancer [84], colon cancer [56], high-grade serous ovarian cancer [85], and acute lymphoblastic leukemia [47].